SHL Telemedicine continues implementation of its strategic plan and expands the use of SmartHeart™ technology in the US. Key executives join the SHL US enterprise

Tel Aviv / Zurich, 16 February 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that it has commenced manning key positions for its US operations, as part of its strategy to significantly expand the use of SmartHeart™ technology in the US.